DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avastin (Bevacizumab) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (1648)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Avastin (Bevacizumab) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 1648   Next >>

Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Bile Duct Cancer

Tarceva
    Indication: Product Used FOR Unknown Indication



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Tarceva
    Indication: Malignant Respiratory Tract Neoplasm

Avastin
    Indication: Product Used FOR Unknown Indication



Possible Avastin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Pancreatic Carcinoma

Xeloda
    Indication: Pancreatic Carcinoma

Tarceva
    Indication: Pancreatic Carcinoma



Possible Avastin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Hepatic Neoplasm Malignant

Avastin
    Indication: Renal Cancer



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Brain Neoplasm

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin

Tarceva
    Indication: Product Used FOR Unknown Indication

Avastin
    Indication: Brain Neoplasm Malignant



Possible Avastin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Tarceva
    Indication: Metastases To Nervous System

Avastin
    Indication: Product Used FOR Unknown Indication

Tarceva
    Indication: Lung Neoplasm Malignant



Possible Avastin side effects in male

Reported by a physician from Algeria on 2012-08-27

Patient: male

Reactions: Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Glioblastoma

Irinotecan Hydrochloride
    Indication: Glioblastoma



Possible Avastin side effects in male

Reported by a physician from Netherlands on 2012-08-27

Patient: male

Reactions: Dyspnoea, Respiratory Failure, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Colorectal Cancer
    Start date: 2010-12-06

Oxaliplatin
    Indication: Colorectal Cancer
    Start date: 2010-12-06

Xeloda
    Administration route: Oral
    Indication: Colorectal Cancer
    Start date: 2010-12-06

Other drugs received by patient: Glyburide; Rosuvastatin; Augmentin '500'; Telmisartan



Possible Avastin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Tarceva
    Indication: Lung Neoplasm Malignant

Avastin
    Indication: Product Used FOR Unknown Indication



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in female

Reported by a physician from France on 2012-08-27

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Skin Mass, Disease Progression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin

Other drugs received by patient: Cyclophosphamide



Possible Avastin side effects in 73 year old

Reported by a physician from Canada on 2012-08-27

Patient: 73 year old

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Tarceva
    Indication: Bile Duct Cancer

Tarceva
    Indication: Pancreatic Carcinoma
    Start date: 2005-06-01

Avastin
    Indication: Pancreatic Carcinoma
    Start date: 2005-06-23



Possible Avastin side effects in 41 year old male

Reported by a physician from Austria on 2012-08-27

Patient: 41 year old male

Reactions: Neoplasm Progression, General Physical Health Deterioration

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Brain Neoplasm Malignant

Irinotecan Hydrochloride
    Indication: Brain Neoplasm Malignant



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-27

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Lung Neoplasm Malignant

Tarceva
    Indication: Lung Neoplasm Malignant



Possible Avastin side effects in female

Reported by a physician from United States on 2012-08-24

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Hepatic Neoplasm Malignant

Avastin
    Indication: Renal Cancer



Possible Avastin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: female, weighing 66.7 kg (146.8 pounds)

Reactions: Intestinal Obstruction

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Metastatic Uterine Cancer
    Start date: 2011-03-21
    End date: 2011-06-23

Avastin
    Start date: 2011-11-07
    End date: 2012-02-23

Other drugs received by patient: Abraxane; Taxol; Doxil; Carboplatin



Possible Avastin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Pancreatic Carcinoma

Tarceva
    Indication: Pancreatic Carcinoma

Xeloda
    Indication: Pancreatic Carcinoma



Possible Avastin side effects in male

Reported by a physician from United Kingdom on 2012-08-23

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: most recent dose: 02/may/2012; most recent dose: 96 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21

Xeloda
    Dosage: most recent dose: 09/may/2012 and most recent dose: 2500 mg daily
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-03-21

Cisplatin
    Dosage: most recent dose: 02/may/2012; most recent dose: 110 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21

Avastin
    Dosage: most recent dose: 02/may/2012; most recent dose: 577 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21



Possible Avastin side effects in male

Reported by a physician from Lebanon on 2012-08-23

Patient: male, weighing 74.5 kg (163.9 pounds)

Reactions: Abscess Neck, Pharyngeal Fistula, Disseminated Intravascular Coagulation, Vascular Pseudoaneurysm, Pharyngeal Ulceration, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin

Other drugs received by patient: Fluorouracil; Oxaliplatin; Bisoprolol Fumarate



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: male

Reactions: Colon Cancer Metastatic

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Glioblastoma Multiforme

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in

Reported by a physician from South Africa on 2012-08-23

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a consumer/non-health professional from Australia on 2012-08-22

Patient: male

Reactions: Death, Fatigue

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in female

Reported by a physician from United States on 2012-08-22

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



Possible Avastin side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017